Thomas, Victoria E.
Metlock, Faith E.
Hines, Anika L.
Commodore-Mensah, Yvonne
Brewer, LaPrincess C. http://orcid.org/0000-0002-6468-9324
Funding for this research was provided by:
American Heart Association (19AMFDP35040005)
Bristol-Myers Squibb Foundation
Centers for Disease Control and Prevention (CDC-DP18-1817)
National Institute of Nursing Research (T32NR020315)
National Institute on Minority Health and Health Disparities (5P50MD017348-02-8183)
American College of Cardiology/Association Black Cardiologists Merck Research Fellowship Award
NHLBI Division of Intramural Research (1K01HL152011)
American Heart Association Career Development Award (940494)
Article History
Accepted: 2 June 2023
First Online: 10 July 2023
Declarations
:
: Dr. Thomas reports honorarium from Pfizer for speaking at their Heart to Heart for ATTR cardiomyopathy. The other authors declare that they have no conflict of interest.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).